Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF ...
Q2 2023
Aug 14, 2023
Q1 2023
Apr 17, 2023
FY 2022
Dec 31, 2022
Q4 2022
Q3 2022
Nov 11, 2022